KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Other Working Capital Changes (2016 - 2025)

Globus Medical (GMED) has disclosed Other Working Capital Changes for 15 consecutive years, with -$17.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 327.67% year-over-year to -$17.8 million, compared with a TTM value of -$11.1 million through Dec 2025, down 951.18%, and an annual FY2025 reading of -$11.1 million, down 951.18% over the prior year.
  • Other Working Capital Changes was -$17.8 million for Q4 2025 at Globus Medical, down from $7.5 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $8.1 million in Q3 2022 and bottomed at -$17.8 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is $156550.0, with a median of $280000.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes plummeted 2302.93% in 2021, then surged 581.21% in 2025.
  • Year by year, Other Working Capital Changes stood at $5.4 million in 2021, then crashed by 36.37% to $3.4 million in 2022, then tumbled by 170.87% to -$2.4 million in 2023, then tumbled by 71.62% to -$4.2 million in 2024, then tumbled by 327.67% to -$17.8 million in 2025.
  • Business Quant data shows Other Working Capital Changes for GMED at -$17.8 million in Q4 2025, $7.5 million in Q3 2025, and $3.7 million in Q2 2025.